HD-OPM Archive
Hashtags

#apob

61 posts

Full-fat yogurt lowered ApoB while yogurt with butter raised it in a crossover trial

Apr 02, 2025 · Louis Nervegna ♥ 17 · 💬 24 Meat, eggs & dairy

Louis summarizes a randomized crossover study that matched saturated fat in full-fat yogurt versus low-fat yogurt mixed with butter for 4 weeks each. The butter version raised ApoB while full-fat yogurt lowered it, which the authors attribute to the milk fat globule membrane (MFGM) that stays intact in yogurt but is lost in butter. This may partly explain yogurt's favorable epidemiology.

Full-fat yogurt lowered ApoB while low-fat yogurt plus butter raised it in a crossover RCT

Jun 07, 2024 · Louis Nervegna ♥ 21 · 💬 15 ↩ 1 Meat, eggs & dairy

Louis summarizes a randomized crossover trial matching saturated fat between full-fat yogurt and low-fat yogurt with added butter. Despite equal saturated fat, the butter arm raised ApoB while full-fat yogurt lowered it, which the study attributes to the milk fat globule membrane (MFGM) that is intact in yogurt but lost in butter. He suggests this may partly explain why yogurt looks better than other dairy in epidemiology.

NLA consensus clarifies when to measure ApoB and matching LDL-C thresholds

Dec 13, 2025 · Louis Nervegna ♥ 8 · 💬 19 LDL, ApoB & lipid panel

Shared from Gokhan Can: a summary of the National Lipid Association's Expert Clinical Consensus on apoB testing. ApoB is a more accurate predictor than LDL-C when the two diverge, particularly after statins, and testing is suggested for borderline-risk patients deciding on a statin or those considering intensifying therapy, with apoB thresholds matching LDL-C goals.

U-shaped ApoB-mortality curve turns linear after adjusting for bilirubin and malnutrition

Jun 01, 2024 · Louis Nervegna ♥ 13 · 💬 5 ↩ 1 LDL, ApoB & lipid panel

Louis explains a 2022 Chinese cohort of about 36,500 people showing the commonly observed U-shaped relationship between ApoB and all-cause mortality disappears once comorbidities, bilirubin and malnutrition are corrected for. Low ApoB at older ages appears to be a consequence of illness and wasting rather than a cause of death, consistent with RCT and Mendelian randomization evidence that the low-end increase is not causal.

Psyllium lowers LDL about 13 mg/dL across 28 trials by trapping bile acids

Oct 31, 2026 · Louis Nervegna ♥ 15 · 💬 4 Carbs, fiber, sugar & whole grains

A shared explainer says psyllium lowers LDL by about 13 mg/dL across 28 randomized trials, and that the mechanism is mechanical: its viscous gel traps bile acids so the liver pulls cholesterol from the blood to make more, upregulating LDL receptors. It does not absorb cholesterol directly or scrub the gut, which is why most other soluble fibers do not work the same way.

Lowering LDL or ApoB is no cure: residual risk persists in every trial; age matters most

Aug 20, 2024 · Louis Nervegna ♥ 25 · 💬 2 LDL, ApoB & lipid panel

The post argues that although aggressive LDL/ApoB lowering reduces risk in many RCTs, considerable residual risk remains in every trial, rising with age. It lists other risk factors (family history, blood pressure, smoking, weight, inflammation, diet, inactivity, insulin resistance/diabetes) and says age is the biggest risk factor, by over 10x versus LDL or ApoB.

Coconut oil raises LDL and ApoB, long-term outcomes unknown; MCT oil is a cleaner option

Oct 16, 2025 · Louis Nervegna ♥ 13 · 💬 2 Fats & oils (saturated fat, seed oils, omega-6, olive oil)

Louis summarizes a Nutrition Made Simple video: there are few long-term studies of coconut oil and heart disease, so claims rely on short-term biomarker studies. Because it is 80-90% saturated fat it raises LDL and ApoB (though less than butter); its HDL rise is unlikely protective, and he suggests plain MCT oil if one wants MCT benefits.

U-shaped ApoB-mortality curve turns linear after adjustment in 36,500 people

Jan 13, 2025 · Louis Nervegna ♥ 10 · 💬 2 LDL, ApoB & lipid panel

Louis explains that the U-shaped curve between ApoB or LDL and mortality is not causal at low levels per RCTs and Mendelian randomization. A 2022 Chinese cohort of 36,500 showed the curve becomes linear after correcting for comorbidities, bilirubin and wasting-related malnutrition. He clarifies that 'metabolic vulnerability' is a broad set of age-related disease processes, not simply insulin resistance, and is the source of the reverse causality.

High HDL tracks with lower risk in UK Biobank, but HDL-raising drugs have failed

Oct 28, 2026 · Louis Nervegna ♥ 7 · 💬 3 ↩ 1 LDL, ApoB & lipid panel

Louis explains that a viral UK Biobank graph shows higher HDL linked to lower ASCVD risk at any LDL/ApoB, as dozens of earlier observational studies have, though the effect size here is larger. Every randomized HDL-raising drug trial failed on hard outcomes, and Mendelian randomization shows no lifetime benefit from genes raising HDL, so HDL is thought to be a proxy for insulin resistance, which is better measured directly.

Swapping refined carbs for unsaturated fat lowers LDL: meta-analysis of 60 feeding trials

Oct 08, 2025 · Louis Nervegna ♥ 5 · 💬 2 Fats & oils (saturated fat, seed oils, omega-6, olive oil)

A meta-analysis of 60 controlled human feeding trials found that replacing carbohydrate calories with monounsaturated or polyunsaturated fat lowers LDL cholesterol, while saturated fat raises it. The effect looked largest for polyunsaturated fat, which is why choosing oils and nuts over refined starch and sugar helps the lipid profile.

Berberine 500 mg twice daily lowered ApoB in two trials; CVD prevention unproven

Oct 29, 2026 · Louis Nervegna ♥ 1 Supplements & vitamins

A shared summary says two randomized trials of 500 mg berberine twice daily reduced ApoB, with a reduction nearly three times greater in women, though across separate trials. A newer study of 84 men identified a 'Berberine Signature' of 92 proteins linked to about 13% lower odds of ischemic heart disease in UK Biobank, but those participants were not necessarily taking berberine, so it does not prove prevention.